Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 143,351	$ 98,679
Marketable securities	73,952	39,463
Prepaid expenses and other current assets	4,036	6,561
Total current assets	221,339	144,703
Property and equipment, net	10,113	2,073
Operating right-of-use assets	4,278	1,564
Restricted cash	100	100
Other long-term assets	4,411	100
Total assets	240,241	148,540
Current liabilities:
Accounts payable	14,189	3,311
Accrued expenses and other current liabilities	33,177	8,025
Deferred revenue, current	6,941	10,493
Total current liabilities	54,307	21,829
Deferred revenue, non-current		5,489
Operating lease liabilities, net of current portion	4,769	1,340
Total liabilities	59,076	28,658
Commitments and contingencies (Note 7)
Stockholders' equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding at December 31, 2024 and 2023
Common stock, $0.0001 par value; 300,000,000 shares authorized at December 31, 2024 and 2023; 64,460,829 and 43,251,778 shares issued and outstanding at December 31, 2024 and 2023, respectively	6	4
Additional paid-in capital	696,872	342,663
Accumulated other comprehensive income	57	22
Accumulated deficit	(515,770)	(222,807)
Total stockholders' equity	181,165	119,882
Total liabilities and stockholders' equity	$ 240,241	$ 148,540